追踪透明细胞肾细胞癌从原发灶到转移灶的非遗传演化:TRACERx Renal研究
该研究对TRACERx Renal研究中79例患者的243份样本进行基因组-转录组联合分析,揭示透明细胞肾细胞癌存在广泛的非遗传性瘤内异质性,其中超过40%不能归因于遗传改变。研究观察到肿瘤向特定表型特征的趋同演化、肿瘤与T细胞库的共演化,以及肿瘤微环境从抗肿瘤向免疫抑制状态的纵向转变,后者与9p缺失和SETD2突变的晚期驱动事件相关。
要点
- 超过40%的瘤内异质性不能归因于遗传改变,提示非遗传演化在ccRCC中普遍存在。
- 肿瘤趋同演化至细胞增殖、代谢重编程及高非整倍体下 putative cGAS-STING 抑制因子过表达等表型。
- 肿瘤微环境从抗肿瘤向免疫抑制状态纵向转变,与9p缺失和SETD2突变获得相关。
核心结论
- 研究揭示了ccRCC中具有临床相关性且此前被低估的非遗传演化模式。
研究设计与样本
- 对TRACERx Renal研究中79例患者的243份样本进行基因组-转录组联合分析。
主要发现
- 发现普遍存在的非遗传性瘤内异质性,其中超过40%不能归因于遗传改变。
- 观察到肿瘤向细胞增殖、代谢重编程及高非整倍体下 putative cGAS-STING 抑制因子过表达等特定表型特征的趋同演化。
- 发现肿瘤与T细胞库之间的共演化。
- 发现肿瘤微环境从抗肿瘤状态向免疫抑制状态的纵向转变,与复发性晚期ccRCC驱动事件9p缺失和SETD2突变的获得相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
While the key aspects of genetic evolution and their clinical implications in clear cell renal-cell carcinoma (ccRCC) are well-documented, how genetic features co-evolve with the phenotype and tumor microenvironment (TME) remains elusive. Here, through joint genomic-transcriptomic analysis of 243 samples from 79 patients recruited to the TRACERx Renal study, we identify pervasive non-genetic intratumor heterogeneity, with over 40% not attributable to genetic alterations. By integrating tumor transcriptomes and phylogenetic structures, we observe convergent evolution to specific phenotypic traits, including cell proliferation, metabolic reprogramming and overexpression of putative cGAS-STING repressors amid high aneuploidy. We also uncover a co-evolution between the tumor and the T cell repertoire, as well as a longitudinal shift in the TME from an anti-tumor to an immunosuppressive state, linked to the acquisition of recurrently late ccRCC drivers 9p loss and SETD2 mutations. Our study reveals clinically-relevant and hitherto underappreciated non-genetic evolution patterns in ccRCC.
引用
- Fernández-Sanromán Á, Fendler A, Tan BJY, et al. Tracking Nongenetic Evolution from Primary to Metastatic ccRCC: TRACERx Renal. Cancer Discov. 2025. PMID: 39774619. doi:10.1158/2159-8290.CD-24-0499
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。